Viewing Study NCT00189358


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT00189358
Status: COMPLETED
Last Update Posted: 2010-07-20
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
Sponsor: AGO Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module